Compare EPM & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EPM | OSUR |
|---|---|---|
| Founded | 2003 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 158.2M | 174.3M |
| IPO Year | 1996 | 2000 |
| Metric | EPM | OSUR |
|---|---|---|
| Price | $4.42 | $2.83 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $4.93 | $3.00 |
| AVG Volume (30 Days) | 344.1K | ★ 431.5K |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | ★ 11.19% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | $43,229,621.00 | ★ $167,064,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.11 | $3.70 |
| P/E Ratio | $85.10 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.19 | $2.08 |
| 52 Week High | $5.70 | $4.22 |
| Indicator | EPM | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 61.27 | 53.32 |
| Support Level | $4.05 | $2.65 |
| Resistance Level | $4.64 | $3.05 |
| Average True Range (ATR) | 0.17 | 0.12 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 64.00 | 50.56 |
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.